Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Pearce, LA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 40 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Bailey, RD; Hart, RG; Benavente, O; Pearce, LA
      Recurrent brain hemorrhage is more frequent than ischemic stroke after intracranial hemorrhage

      NEUROLOGY
    2. Hart, RG; Pearce, LA; Miller, VT; Anderson, DC; Rothrock, JF; Albers, GW; Nasco, E
      Cardioembolic vs. noncardioembolic strokes in atrial fibrillation: Frequency and effect of antithrombotic agents in the stroke prevention in atrial fibrillation studies

      CEREBROVASCULAR DISEASES
    3. Hart, RG; Pearce, LA; Rothbart, RM; McAnulty, JH; Asinger, RW; Halperin, JL
      Stroke with intermittent atrial fibrillation: Incidence and predictors during aspirin therapy

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    4. Dolezal, O; Pearce, LA; Lawrence, LJ; McCoy, AJ; Hudson, PJ; Kortt, AA
      ScFv multimers of the anti-neuraminidase antibody NC10: shortening of the linker in single-chain Fv fragment assembled in V-L to V-H orientation drives the formation of dimers, trimers, tetramers and higher molecular mass multimers

      PROTEIN ENGINEERING
    5. Hart, RG; Pearce, LA
      Antithrombotic therapy to prevent stroke in patients with atrial fibrillation - In response

      ANNALS OF INTERNAL MEDICINE
    6. Pearce, LA; Hart, RG; Halperin, JL
      Assessment of three schemes for stratifying stroke risk in patients with nonvalvular atrial fibrillation

      AMERICAN JOURNAL OF MEDICINE
    7. Hart, RG; Benavente, O; Pearce, LA
      Increased risk of intracranial hemorrhage when aspirin is combined with warfarin: A meta-analysis and hypothesis

      CEREBROVASCULAR DISEASES
    8. Lind, SE; Pearce, LA; Feinberg, WM; Bovill, EG
      Clinically significant differences in the International Normalized Ratio measured with reagents of different sensitivities

      BLOOD COAGULATION & FIBRINOLYSIS
    9. Goldman, ME; Pearce, LA; Hart, RG; Zabalgoitia, M; Asinger, RW; Safford, R; Halperin, JL
      Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: I. Reduced flow velocity in the left atrial appendage (The Stroke Prevention in Atrial Fibrillation [SPAF-III] study)

      JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY
    10. Asinger, RW; Koehler, J; Pearce, LA; Zabalgoitia, M; Blackshear, JL; Fenster, PE; Strauss, R; Hess, D; Pennock, GD; Rothbart, RM; Halperin, JL
      Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: II. Dense spontaneous echocardiographic contrast (The Stroke Prevention in Atrial Fibrillation [SPAF-III] study)

      JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY
    11. Feinberg, WM; Macy, E; Cornell, ES; Nightingale, SD; Pearce, LA; Tracy, RP; Bovill, EG
      Plasmin-alpha(2)-antiplasmin complex in patients with atrial fibrillation

      THROMBOSIS AND HAEMOSTASIS
    12. Hart, RG; Pearce, LA; McBride, R; Rothbart, RM; Asinger, RW
      Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation - Analysis of 2012 participants in the SPAF I-III clinical trials

      STROKE
    13. Blackshear, JL; Pearce, LA; Hart, RG; Zabalgoitia, M; Labovitz, A; Asinger, RW; Halperin, JL
      Aortic plaque in atrial fibrillation - Prevalence, predictors, and thromboembolic implications

      STROKE
    14. Feinberg, WM; Pearce, LA; Hart, RG; Cushman, M; Cornell, ES; Lip, GYH; Bovill, EG
      Markers of thrombin and platelet activity in patients with atrial fibrillation - Correlation with stroke among 1531 participants in the stroke prevention in atrial fibrillation III study

      STROKE
    15. Hart, RG; Benavente, O; McBride, R; Pearce, LA
      Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: A meta-analysis

      ANNALS OF INTERNAL MEDICINE
    16. Blackshear, JL; Zabalgoitia, M; Pennock, G; Fenster, P; Strauss, R; Halperin, J; Asinger, R; Pearce, LA
      Warfarin safety and efficacy in patients with thoracic aortic plaque and atrial fibrillation

      AMERICAN JOURNAL OF CARDIOLOGY
    17. Dittrich, HC; Pearce, LA; Asinger, RW; McBride, R; Webel, R; Zabalgoitia, M; Pennock, GD; Safford, RE; Rothbart, RM; Halperin, JL; Hart, RG
      Left atrial diameter in nonvalvular atrial fibrillation: An echocardiographic study

      AMERICAN HEART JOURNAL
    18. LILLEY GG; BARBOSA JARG; PEARCE LA
      EXPRESSION IN ESCHERICHIA-COLI OF THE PUTATIVE N-ACETYLNEURAMINATE LYASE GENE (NANA) FROM HAEMOPHILUS-INFLUENZAE - OVERPRODUCTION, PURIFICATION, AND CRYSTALLIZATION

      Protein expression and purification
    19. ZABALGOITIA M; HALPERIN JL; PEARCE LA; BLACKSHEAR JL; ASINGER RW; HART RG
      TRANSESOPHAGEAL ECHOCARDIOGRAPHIC CORRELATES OF CLINICAL RISK OF THROMBOEMBOLISM IN NONVALVULAR ATRIAL-FIBRILLATION

      Journal of the American College of Cardiology
    20. ANDERSON DC; HALPERIN JL; HART RG; MCANULTY JH; MCBRIDE R; PEARCE LA; SHERMAN DG
      PATIENTS WITH NONVALVULAR ATRIAL-FIBRILLATION AT LOW-RISK OF STROKE DURING TREATMENT WITH ASPIRIN - STROKE PREVENTION IN ATRIAL-FIBRILLATION III STUDY

      JAMA, the journal of the American Medical Association
    21. BLACKSHEAR JL; PEARCE LA; HART RG
      PREDICTORS OF AORTIC PLAQUE AND COMPLEX PLAQUE IN THE STROKE PREVENTION IN ATRIAL-FIBRILLATION (SPAF)-III STUDY

      Circulation
    22. BLACKSHEAR JL; PEARCE LA; ZABALGOITIA M
      LOW-RISK OF CHOLESTEROL CRYSTAL EMBOLIZATION (CCE) DURING WARFARIN THERAPY IN PATIENTS WITH AORTIC PLAQUE (AP)

      Circulation
    23. BLACKSHEAR JL; PEARCE LA; REDFIELD MM
      IS BRAIN NATRIURETIC PEPTIDE (BNP) A MARKER FOR PROGNOSIS IN CHRONIC ATRIAL-FIBRILLATION (AF)

      Circulation
    24. ZABALGOITIA M; LEONARD A; BLACKSHEAR JL; SAFFORD R; BAKER VS; FENSTER P; PENNOCK GD; OHM J; HUERTA BJ; STRAUSS R; MCKENZIE M; HARTMCARTHUR P; GRAMBERG M; HOUSTON H; CHAN KL; BIGGS J; IVES A; ROTHBART R; MURRAY D; LOUTFI H; LYNCH JJ; CARLSON L; LABOVITZ AJ; VIGIL A; ASINGER RW; DICK CD; NEWBURG SM; FIFIELD J; KHANDHERIA BK; HOLLAND AE; TUCKER KR; GOLDMAN ME; ROTHLAUF EB; HESS D; YOUNG L; MEGO DM; BOYD S; WILSON D; NOLTE B; EDWARDS C; MEZEI L; RIGGIO S; GIRAUD G; MARCHANT C; TIMBERG J; DITTRICH HC; KEEN W; KERRIDGE C; BERNARD S; BATTINELLI N; ATWOOD JE; QUAGLIETTI S; ALPERT MA; MASSEY CV; HUPP C; KOEHLER J; PEARCE LA; HALPERIN JL; HART RG; MARLER JR; DEMARIA AN; TAJIK AJ; WEYMAN A
      TRANSESOPHAGEAL ECHOCARDIOGRAPHIC CORRELATES OF THROMBOEMBOLISM IN HIGH-RISK PATIENTS WITH NONVALVULAR ATRIAL-FIBRILLATION

      Annals of internal medicine
    25. PEARCE LA; ODDIE GW; COIA G; KORTT AA; HUDSON PJ; LILLEY GG
      LINEAR GENE FUSIONS OF ANTIBODY FRAGMENTS WITH STREPTAVIDIN CAN BE LINKED TO BIOTIN-LABELED SECONDARY MOLECULES TO FORM BISPECIFIC REAGENTS

      Biochemistry and molecular biology international
    26. KORTT AA; LAH M; ODDIE GW; GRUEN CL; BURNS JE; PEARCE LA; ATWELL JL; MCCOY AJ; HOWLETT GJ; METZGER DW; WEBSTER RG; HUDSON PJ
      SINGLE-CHAIN FV FRAGMENTS OF ANTI-NEURAMINIDASE ANTIBODY NC10 CONTAINING 5-RESIDUE AND 10-RESIDUE LINKERS FORM DIMERS AND WITH ZERO-RESIDUELINKER A TRIMER

      Protein engineering
    27. FEINBERG WM; CORNELL ES; NIGHTINGALE SD; PEARCE LA; TRACY PT; HART RG; BOVILL EG
      RELATIONSHIP BETWEEN PROTHROMBIN ACTIVATION FRAGMENT F1.2 AND INTERNATIONAL NORMALIZED RATIO IN PATIENTS WITH ATRIAL-FIBRILLATION

      Stroke
    28. FEINBERG WM; MACY EM; NIGHTINGALE SD; CORNELL ES; PEARCE LA; BOVILL EG
      PLASMIN-ALPHA(2) ANTIPLASMIN LEVELS IN PATIENTS WITH ATRIAL-FIBRILLATION

      Stroke
    29. ATWELL JL; PEARCE LA; LAH M; GRUEN LC; KORTT AA; HUDSON PJ
      DESIGN AND EXPRESSION OF A STABLE BISPECIFIC SCFV DIMER WITH AFFINITYFOR BOTH GLYCOPHORIN AND N9 NEURAMINIDASE

      Molecular immunology
    30. BLACKSHEAR JL; SAFFORD RE; PEARCE LA
      F-AMPLITUDE, LEFT ATRIAL APPENDAGE VELOCITY, AND THROMBOEMBOLIC RISK IN NONRHEUMATIC ATRIAL-FIBRILLATION

      Clinical cardiology
    31. MILLER VT; PEARCE LA; FEINBERG WM; ROTHROCK JF; ANDERSON DC; HART RG
      DIFFERENTIAL EFFECT OF ASPIRIN VERSUS WARFARIN ON CLINICAL STROKE TYPES IN PATIENTS WITH ATRIAL-FIBRILLATION

      Neurology
    32. FEINBERG WM; MILLER VT; ROTHROCK JF; HART RG; PEARCE LA
      DIFFERENTIAL EFFECT OF ASPIRIN AND WARFARIN ON STROKE SUBTYPES IN PATIENTS WITH ATRIAL-FIBRILLATION

      Stroke
    33. BLACKSHEAR JL; SAFFORD RE; PEARCE LA
      COARSENESS OF NONRHEUMATIC ATRIAL-FIBRILLATION - AN ANALYSIS OF 464 PATIENTS FOLLOWED FOR 1.3 YEARS

      Journal of the American College of Cardiology
    34. MCBRIDE R; CHESEBRO JH; WIEBERS DO; HOLLAND AE; LINKER S; BARDSLEY WT; KOPECKY S; LITIN SC; MEISSNER I; ZERBE DM; FLAKER GC; WEBEL R; NOLTE B; STEVENSON P; BYER J; JENKINS JS; WRIGHT W; ANDERSON DC; ASINGER RW; NEWBURG SM; BUNDLIE SR; FARMER CC; KOLLER RL; HAUGLAND JM; NANCE MA; TARREL RM; DUNBAR DN; JORGENSEN CR; SHARKEY SW; LEONARD ADS; KANTER MC; SOLOMON DH; ZABALGOITIA M; MCANULTY JH; MARCHANT C; COULL BM; KELLEY RE; CHAHINE R; PALERMO M; TEIXEIRO P; FELDMAN G; HAYWARD A; MACMILLAN K; GANDARA E; ANDERSON W; BLANK N; STRAUSS R; FEINBERG WM; VOLD BK; KERN KB; APPLETON C; BRUCK D; DORR S; DITTRICH HC; ROTHROCK JF; KERRIDGE C; LOGAN WR; HAMILTON WP; GREEN BJ; BACON RS; HELGASON CM; KONDOS GT; HOFF J; MCRAE RP; HALPERIN JL; ROTHLAUF EB; WEINBERGER JM; GOLDMAN ME; MILLER VT; HOCKERSMITH CJ; COHEN BA; JANOSIK DL; CADELL DJ; KELLERMAN L; GOMEZ CR; LABOVITZ AJ; ROTHBART RM; BAILEY GH; BURKHARDT C; HORWITZ L; BLACKSHEAR JL; WEAVER L; BAKER V; LEE G; LANE G; RUBINO F; SAFFORD R; KRONMAL RA; PEARCE LA; FLETCHER KA; NASCO E; HART RG; SHERMAN DG; TALBERT RL; DACY TL; HERBERLING PA
      WARFARIN VERSUS ASPIRIN FOR PREVENTION OF THROMBOEMBOLISM IN ATRIAL-FIBRILLATION - STROKE PREVENTION IN ATRIAL-FIBRILLATION-II STUDY

      Lancet
    35. HART RG; PEARCE LA; HALPERIN JL; MILLER VT
      ASPIRIN IN ELDERLY ATRIAL-FIBRILLATION PATIENTS

      Stroke
    36. KANTER MC; TEGELER CH; PEARCE LA; WEINBERGER J; FEINBERG WM; ANDERSON DC; GOMEZ CR; ROTHROCK JF; HELGASON CM; HART RG
      CAROTID STENOSIS IN PATIENTS WITH ATRIAL-FIBRILLATION - PREVALENCE, RISK-FACTORS, AND RELATIONSHIP TO STROKE IN THE STROKE PREVENTION IN ATRIAL-FIBRILLATION STUDY

      Archives of internal medicine
    37. HESS JC; SEDGHINASAB M; MOE RE; PEARCE LA; TAPPER D
      GROWTH-FACTOR PROFILES IN BREAST CYST FLUID IDENTIFY WOMEN WITH INCREASED BREAST-CANCER RISK

      The American journal of surgery
    38. WEINBERGER J; KANTER MC; PEARCE LA
      CAROTID STENOSIS IN PATIENTS WITH ATRIAL-FIBRILLATION - PREVALENCE AND RISK-FACTORS IN THE STROKE PREVENTION IN ATRIAL-FIBRILLATION STUDY

      Neurology
    39. MCANULTY JH; HART RG; PEARCE LA
      ATRIAL-FIBRILLATION AND THROMBOEMBOLISM - PREDICTORS OF HIGH-RISK DURING ASPIRIN THERAPY

      Circulation
    40. BLACKSHEAR JL; PEARCE LA; ASINGER RW; DITTRICH HC; GOLDMAN ME; ZABALGOITIA M; ROTHBART RM; HALPERIN JL
      MITRAL REGURGITATION ASSOCIATED WITH REDUCED THROMBOEMBOLIC EVENTS INHIGH-RISK PATIENTS WITH NONRHEUMATIC ATRIAL-FIBRILLATION

      The American journal of cardiology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/01/21 alle ore 09:35:04